Revenue
$249.13M
Fiscal year ended 2026-03-31Operating income
$18.51M
Fiscal year ended 2026-03-31Free cash flow
$39.58M
Fiscal year ended 2026-03-31MESA LABORATORIES INC /CO/ (MLAB) reported revenue of $249.13M and net income of $6.71M for the fiscal year ended 2026-03-31. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from MESA LABORATORIES INC /CO/’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Industrial Instruments For Measurement, Display, and Control.
Income
| Metric | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 | 2020-03-31 | 2019-03-31 | 2018-03-31 | 2017-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $249.13M | $240.98M | $216.19M | $219.08M | $184.34M | $133.94M | $117.69M | $103.14M | $96.18M | $93.66M |
| Cost of revenue | $90.86M | $90.11M | $82.94M | $85.39M | $75.24M | $46.92M | $52.32M | $42.22M | $41.56M | $40.43M |
| Gross profit | $158.27M | $150.87M | $133.25M | $133.69M | $109.09M | $87.01M | $65.36M | $60.92M | $54.62M | $53.24M |
| Operating income | $18.51M | $16.34M | -$272.08M | $3.32M | $4.70M | $12.36M | $7.92M | $9.78M | $2.18M | $16.31M |
| Net income | $6.71M | -$1.97M | -$254.25M | $930.00K | $1.87M | $3.27M | Unavailable | Unavailable | Unavailable | Unavailable |
| Research & development | $20.31M | $19.52M | $19.30M | $20.49M | $15.77M | $10.39M | $6.36M | $3.51M | $3.54M | $4.16M |
| Weighted-average diluted shares | shares 5.56M | shares 5.42M | shares 5.39M | shares 5.36M | shares 5.34M | shares 5.12M | shares 4.37M | shares 4.03M | shares 3.77M | shares 3.84M |
| Pretax income | $12.01M | $5.96M | -$275.65M | -$389.00K | $3.57M | $2.30M | $3.86M | $8.62M | $301.00K | $14.30M |
| Income tax expense | $5.30M | $7.94M | -$21.40M | -$1.32M | $1.70M | -$971.00K | $2.08M | $1.14M | $3.26M | $3.11M |
| Diluted EPS | $1.21 | $-0.36 | $-47.20 | $0.17 | $0.35 | $0.64 | $0.41 | $1.86 | $-0.79 | $2.91 |
| Selling, general & administrative | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| General & administrative | $78.66M | $73.33M | $72.87M | $72.44M | $60.31M | $45.79M | $38.17M | $31.30M | $26.26M | $22.81M |
| Selling & marketing | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Balance
| Metric | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 | 2020-03-31 | 2019-03-31 | 2018-03-31 | 2017-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $26.93M | $27.32M | $28.21M | $32.91M | $49.35M | $263.86M | $81.38M | $10.18M | $5.47M | $5.82M |
| Total assets | $427.75M | $433.35M | $446.80M | $661.83M | $707.37M | $601.48M | $409.11M | $156.77M | $164.10M | $171.73M |
| Current assets | $106.27M | $102.68M | $109.35M | $118.98M | $124.32M | $303.75M | $122.79M | $33.62M | $31.99M | $35.78M |
| Total liabilities | $241.50M | $273.52M | $301.40M | $268.35M | $313.57M | $195.25M | $189.10M | $45.46M | $64.74M | $73.91M |
| Current liabilities | $61.90M | $163.96M | $44.31M | $43.36M | $48.06M | $32.58M | $26.01M | $23.66M | $17.29M | $16.57M |
| Total equity incl. NCI | $186.24M | $159.83M | $145.39M | $393.48M | $393.80M | $406.23M | $220.01M | $111.31M | $99.36M | $97.82M |
| Temporary (mezzanine) equity | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Inventory | $26.37M | $25.36M | $32.68M | $34.64M | $24.61M | $11.18M | $11.18M | $6.77M | $9.23M | $13.87M |
| Accounts receivable | $44.10M | $41.97M | $39.06M | $42.55M | $41.22M | $23.79M | $21.13M | $12.52M | $14.30M | $14.32M |
| Goodwill | $186.86M | $181.76M | $180.10M | $286.44M | $291.17M | $160.84M | $141.54M | $66.38M | $65.54M | $72.16M |
| Long-term debt | $67.50M | $71.25M | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | $20.61M | $44.64M | $53.68M |
| Accounts payable | $4.93M | $5.75M | $6.04M | $6.13M | $7.90M | $4.47M | $3.41M | $2.90M | $2.38M | $2.17M |
Cash flow
| Metric | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 | 2020-03-31 | 2019-03-31 | 2018-03-31 | 2017-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $42.83M | $46.81M | $44.13M | $27.98M | $39.22M | $37.07M | $26.99M | $30.55M | $25.72M | $17.30M |
| Capital expenditures | $3.25M | $4.25M | $2.57M | $4.54M | $4.43M | $1.99M | $1.50M | $1.26M | $2.80M | Unavailable |
| Investing cash flow | -$3.25M | -$4.50M | -$81.31M | -$9.49M | -$305.22M | -$1.99M | -$185.58M | -$3.88M | -$17.18M | -$18.40M |
| Financing cash flow | -$41.85M | -$44.51M | $32.84M | -$33.33M | $52.58M | $146.23M | $231.28M | -$21.67M | -$9.02M | $1.15M |
| Net change in cash | -$393.00K | -$893.00K | -$4.70M | -$16.44M | -$214.52M | $182.48M | $71.20M | $4.72M | -$351.00K | $125.00K |
| Stock-based compensation | $17.87M | $13.14M | $11.94M | $12.54M | $11.39M | $9.27M | $5.52M | $4.21M | $1.67M | $1.41M |
| Common dividends paid | $3.52M | $3.47M | $3.45M | $3.41M | $3.34M | $3.16M | $2.72M | $2.46M | $2.41M | $2.36M |
| Common share repurchases | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Depreciation & amortization | Unavailable | Unavailable | Unavailable | $33.82M | $25.07M | $17.66M | $12.99M | $9.43M | $9.47M | $8.74M |
Derived
| Metric | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 | 2020-03-31 | 2019-03-31 | 2018-03-31 | 2017-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Free cash flow | $39.58M | $42.56M | $41.57M | $23.44M | $34.79M | $35.08M | $25.49M | $29.29M | $22.92M | Unavailable |
| Gross margin | 63.5% | 62.6% | 61.6% | 61.0% | 59.2% | 65.0% | 55.5% | 59.1% | 56.8% | 56.8% |
| Operating margin | 7.4% | 6.8% | -125.9% | 1.5% | 2.6% | 9.2% | 6.7% | 9.5% | 2.3% | 17.4% |
| FCF margin | 15.9% | 17.7% | 19.2% | 10.7% | 18.9% | 26.2% | 21.7% | 28.4% | 23.8% | Unavailable |
| SBC / revenue | 7.2% | 5.5% | 5.5% | 5.7% | 6.2% | 6.9% | 4.7% | 4.1% | 1.7% | 1.5% |
| Current ratio | 1.72x | 0.63x | 2.47x | 2.74x | 2.59x | 9.32x | 4.72x | 1.42x | 1.85x | 2.16x |
| Revenue YoY growth | 3.4% | 11.5% | -1.3% | 18.8% | 37.6% | 13.8% | 14.1% | 7.2% | 2.7% | Unavailable |
| Net margin | 2.7% | -0.8% | -117.6% | 0.4% | 1.0% | 2.4% | Unavailable | Unavailable | Unavailable | Unavailable |
| R&D / revenue | 8.2% | 8.1% | 8.9% | 9.4% | 8.6% | 7.8% | 5.4% | 3.4% | 3.7% | 4.4% |
| CapEx / revenue | 1.3% | 1.8% | 1.2% | 2.1% | 2.4% | 1.5% | 1.3% | 1.2% | 2.9% | Unavailable |
| Long-term debt / equity | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Effective tax rate | 44.1% | 133.1% | Unavailable | Unavailable | 47.6% | -42.2% | 54.0% | 13.2% | 1084.1% | 21.8% |
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open MLAB in the interactive workspace to inspect any figure back to its filing.
Source filings
10-Q · Filed 2026-08-10View SEC filing
10-K · Filed 2026-06-03View SEC filing
10-Q · Filed 2026-02-03View SEC filing
10-Q · Filed 2025-11-06View SEC filing
10-Q · Filed 2025-08-05View SEC filing
10-K · Filed 2025-05-28View SEC filing
Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.